A number of other equities analysts have also weighed in on PETQ. Zacks Investment Research lowered shares of ExlService from a “hold” rating to a “sell” rating in a report on Wednesday, July 10th. Guggenheim restated a “buy” rating and issued a $95.00 price objective (up from $90.00) on shares of VF in a report on Thursday, May 23rd. Finally, BidaskClub upgraded shares of Misonix from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, July 3rd. One equities research analyst has rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. PetIQ has a consensus rating of “Buy” and an average price target of $40.71.
Shares of PETQ traded up $0.48 during trading hours on Friday, hitting $36.00. The company had a trading volume of 222,500 shares, compared to its average volume of 413,117. The firm has a market cap of $1.01 billion, a price-to-earnings ratio of 28.80, a P/E/G ratio of 1.93 and a beta of 2.06. The company’s 50 day moving average is $31.56. The company has a current ratio of 2.89, a quick ratio of 1.51 and a debt-to-equity ratio of 0.38. PetIQ has a 52-week low of $21.29 and a 52-week high of $43.93.
In other news, insider Will Santana sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $30.77, for a total transaction of $615,400.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director James Nathan Clarke bought 31,031 shares of PetIQ stock in a transaction dated Wednesday, May 15th. The shares were bought at an average cost of $28.12 per share, for a total transaction of $872,591.72. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 120,291 shares of company stock valued at $3,575,091. 23.79% of the stock is owned by insiders.
Large investors have recently modified their holdings of the company. Raymond James Financial Services Advisors Inc. purchased a new position in shares of PetIQ during the first quarter worth approximately $505,000. Campbell Newman Asset Management Inc. grew its position in shares of PetIQ by 3.8% during the 1st quarter. Campbell Newman Asset Management Inc. now owns 18,080 shares of the company’s stock worth $568,000 after buying an additional 658 shares during the period. Dimensional Fund Advisors LP grew its position in shares of PetIQ by 226.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 95,881 shares of the company’s stock worth $2,250,000 after buying an additional 66,498 shares during the period. BCJ Capital Management LLC acquired a new stake in PetIQ in the 4th quarter valued at approximately $235,000. Finally, Voloridge Investment Management LLC acquired a new stake in PetIQ in the 4th quarter valued at approximately $774,000. 91.47% of the stock is currently owned by institutional investors and hedge funds.
PetIQ Company Profile
PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.